Booming demand for medicinal cannabis from Europe to Australia has seen a South African producer sell all of its output for next year in advance. SafriCanna signed sale deals with Germany and Australia for the bulk of the production, Bassim Haidar, chief executive officer of its largest investor, Optasia, said in an interview. The company started construction of its facilities in the capital, Pretoria, in 2019 and shipped its first flowers in June.
